课题基金 / 基金详情

MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY

MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
有机磷酸盐免疫毒性的分子机制
批准号:
3447734
负责人:
KATHLEEN E. RODGERS
金额:
$4.59万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1989-08-31

项目摘要

项目成果

KATHLEEN E. RODGERS的其他基金

相似基金

相关文献

中文摘要
翻译
细菌中两种杂质抑制免疫的分子机制 有机磷农药、马拉硫磷、乙酰甲胺磷和敌硝硫磷, O,O,S-三甲基硫代硫酸酯和O,S,S-三甲基 二硫代磷酸,将被检测。宏页,通过单元格 分离和重建实验已经被证明是 OOS-TMP治疗对淋巴样细胞影响最大。交通堵塞的原因是 急性给药后巨噬细胞的成熟 将确定OOS-TMP。研究将包括巨噬细胞的变化 细胞表面标志物Ia、Mac-1、Mac-2和F4/80,功能活性和 分泌性产品。结构类似物OSS-TMP的抑制作用 关于细胞溶解效应器的功能将使用 功能定义的细胞毒性T淋巴细胞(CTL)和其他细胞溶解 效应细胞。将阻断小鼠CTL功能的部位(S) 使用共轭形成和钙脉冲技术测定。这个 将使用放射性标记的OSS-TMP和 生化分析。此外,一种改装的比色法 (染料减少)对细胞活力的适用性将进行研究 作为细胞毒活性和细胞抑制力的筛选试验 环境毒物。这项检测可能是标准的替代方法。 台盼蓝拒染法检测细胞活力。
英文摘要
The molecular mechanisms of immune suppression by two impurities in the organosphosphate pesticides, malathion, acephate and fenitrothion, O,O,S-trimethyl phosphorothioate (OOS-TMP) and O,S,S-trimethyl phosphorodithioate, will be examined. Macrophaages, through cell separation and reconstitution experiments, have been shown to be the lymphoid cell most affected by OOS-TMP treatment. The blockage in the maturation of macrophages which occurs following acute administration of OOS-TMP will be identified. Studies will include changes in macrophage cell surface markers, Ia, Mac-1, Mac-2 and F4/80, functional activity and secretory products. The inhibitory effect of a structural analog OSS-TMP on cytolytic effector function will be examined in detail using functionally defined cytotoxic T lymphocytes (CTL) and other cytolytic effector cells. The site(s) of the blockade of murine CTL function will be determined using conjugate formation and Ca2+ pulse techniques. The molecular sites will be identified using radiolabelled OSS-TMP and biochemical analyses. In addition, an adaptation of a colorimetric assay (dye reduction) for cell viability will be investigated for its suitability as a screening assay for the cytotoxic and cytostatic activities of environmental toxicants. This assay may be an alternative to the standard trypan blue exclusion method for assessing cell viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
  • 批准号:
    10530821
  • 项目类别:
  • 资助金额:
    $38.38万
  • 财政年份:
    2020
  • 负责人:
    KATHLEEN E. RODGERS
  • 依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
  • 批准号:
    10396541
  • 项目类别:
  • 资助金额:
    $151.56万
  • 财政年份:
    2020
  • 负责人:
    KATHLEEN E. RODGERS
  • 依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
  • 批准号:
    10644987
  • 项目类别:
  • 资助金额:
    $152.86万
  • 财政年份:
    2020
  • 负责人:
    KATHLEEN E. RODGERS
  • 依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
  • 批准号:
    8058309
  • 项目类别:
  • 资助金额:
    $43.16万
  • 财政年份:
    2010
  • 负责人:
    KATHLEEN E. RODGERS
  • 依托单位:
海外基金